The present device, apparatus, and method relate to the field of adipose tissue treatment and aesthetic body sculpturing.
Liposuction is a popular technique for removal of fat from different sites of a subject's body. The process changes the external contours of the body and sometimes is described as body sculpturing. The fat is removed by a suction device via a cannula inserted into the appropriate site of the body. The process is painful and sometimes causes excessive bleeding.
Recently, improvements have been realized in liposuction procedures by the utilization of electro-magnetic energy or radiation such as an infrared laser radiation delivered through a fiber inserted into a cannula introduced into the treatment site. Laser radiation liquefies the adipose tissue. The liquefied tissue is either removed by suction or left in the subject body, where it gradually dissipates in a uniform way. Laser assisted liposuction is considered to be a more advanced and less invasive procedure when compared to traditional liposuction techniques.
For proper treatment, laser assisted liposuction requires application of high power ten to fifty watt laser energy or radiation. The radiation is applied in a continuous or pulse mode for relatively long periods. Sometimes more than one laser is used on the same treated tissue volume to speed up the treatment. Each of the lasers may operate in a different mode. For example, one of the lasers heats the target tissue volume, and the other one introduces laser power sufficient to destroy the adipose tissue in the same volume. This increases the cost of the equipment and prolongs the treatment session time. In addition, frequent cleaning and maintenance of the fiber tip from process debris will be required. All of the above slows down the treatment process, and in addition affects comfort and cost of procedure to the treated subject.
The present method provides an improvement over currently available techniques addressing these and other existing liposuction problems.
The term “mono-polar configuration” as used in the present disclosure means a configuration consisting of an active treatment electrode and a passive treatment electrode, the latter of which acts as the grounding electrode. Typically, the electrodes are different in size and can be located at a substantial distance from each other. RF induced current affects the tissue area/volume that is proximate to the active electrode.
The term “bi-polar configuration” as used in the present disclosure means that the current passes between two almost identical electrodes that are located a short distance apart from each other. The electrodes are applied to the area/volume of tissue to be treated and the propagation of the current is limited to the area between the electrodes themselves.
The term “needle” or “probe,” as used in the text of the present disclosure means a flexible or rigid light guide configured to be inserted during use into the subject tissue in order to deliver laser energy to a target volume of adipose tissue. In certain embodiments, the needle can be equipped with electrodes and configured during operation to apply RF energy to the treated tissue. The needle can also be configured to conduct a fluid to any part of the needle, and liquefied fat and the fluid from the target volume may be withdrawn. The needle may be a disposable or reusable needle.
The term “tissue” or “skin” as used in the text of the present disclosure means the upper tissue layers, such as epidermis, dermis, adipose tissue, muscles, and deeper located fat tissue.
The term “adipose tissue” used herein may also encompass, fat, and other undesirable tissue elements. The term “adipose tissue” is an example of undesirable or excessive tissue, but it should also be understood that the processes and treatments disclosed are applicable to other classes of tissue.
The term “tissue treatment,” as used in the present disclosure means application of one or more types of energy to the tissue to alter the tissue, such as changing it to a different state, or obtain another desired treatment effect. The desired effect or state may include at least one of adipose tissue destruction, shrinking, breakdown, and skin tightening, haemostasis, inducing fat cells necrosis, inducing fat cells apoptosis, fat redistribution, adiposities (fat cell) size reduction, and cellulite treatment.
The terms “light,” “laser energy,” and “laser radiation” in the context of the present disclosure have the same meaning.
The term “tissue affecting energy” as used in the present disclosure means energy capable of causing a change in the tissue and/or skin or enabling such change. Such energy for example, may be RF energy from one or more areas in the electromagnetic spectrum, optical radiation in the visible or invisible part of electromagnetic spectrum, ultrasound waves energy, and kinetic energy provided by a massaging device.
The term “probe” as used in the present disclosure means any device operative to couple to the tissue or skin energy affecting the tissue/skin. Such device for example, may apply to the tissue RF energy, optical radiation existing in the visible or the invisible part of spectrum, energy from ultrasound waves, kinetic energy provided by a massaging device or some other source of energy.
As used herein, the term “subject” refers to any human or animal subject, as well as objects used to simulate the same for testing purposes.
As used herein, the term “treatment” means a process of coupling to the tissue or skin energy affecting the tissue/skin.
A method and apparatus for adipose tissue treatment in which two types of electromagnetic radiation (or energy) are applied to a volume of tissue to be treated. One type of the electromagnetic energy is RF and the second type of electromagnetic energy is provided by visible or infrared radiation.
In some embodiments, both types of electromagnetic energy are delivered to the target volume subcutaneously by a light guide or needle that includes electrodes. In other embodiments, only one type of energy may be delivered to a target volume.
In some embodiments, the RF energy is delivered to a target volume of the tissue by an electrode applied to the skin. In other embodiments, the energy may be delivered to a target volume by two or more electrodes introduced subcutaneously into the tissue. The energy delivered by the visible or infrared radiation is delivered subcutaneously by a needle or probe, which is introduced into the same target volume of the tissue.
The disclosure is provided by way of non-limiting examples only, with reference to the accompanying drawings, wherein:
The present disclosure presents features, aspects and elements that may be included in one or more embodiments of a needle or probe, apparatus and/or method. As a non-limiting example, one embodiment of the needle or probe includes a tip for a tissue suction probe. The exemplary tip may include a main lumen, a side lumen and an electrode. The main lumen may have an open end that can engage with a suction probe, and a closed end on the opposite side from the open end. In addition, the main lumen may one or more apertures adjacent or near to the closed end of the lumen. The apertures are defined by an edge or rim of the lumen. The first side-lumen extends at least partially along the side of the main lumen and traversing the closed end. The side-lumen may extend along the main lumen in a manner that relative to the main axis of the main lumen is a parallel path, a spiral path, an arbitrary path or some other fashion or combination thereof. The side-lumen extends through or communicates with an outlet located or defined in the closed end of the lumen. The side lumen may be fixedly or permanently attached to the main lumen or may be temporarily attached or removable. The electrodes are disposed along a portion of the outer surface of the tip and extend over a portion of rim. The electrodes also may extend to the inner surface of the lumen.
Additional embodiments may include more than one side-lumen with each side-lumen being configured or operative to carry and deliver a fluid, such as an irrigation fluid, and/or for extracting fluids from the application area. Some embodiments my include one, two, three or more RF electrodes. In the various embodiments, the RF electrodes are configured to induce an RF current between them when connected to a source of RF power, and to heat tissue traversing the aperture and entering into the main lumen of the tip. In other embodiments, multiple electrodes may be included on the tip and one or more of the electrodes can be selected or deselected, enabled or disabled, either manually or automatically. For instance, a switch may be used to enable/disable certain electrodes or groups of electrodes. Likewise, the tip may include sensors, such as capacitive switched to detect when a probe should be enabled or disabled.
The various embodiments may be used for applying electromagnetic radiation generated by one or more different electromagnetic radiation sources to a target volume of tissue. For example, in one application a source of electromagnetic radiation is applied externally so that the radiation penetrates the surface of the tissue and is concentrated in the target volume. A second source of electromagnetic radiation can then be applied to the same target volume by a second source located within the volume of tissue. In such an application, it is desirable to set the level of the first source such that it is insufficient to produce a desired treatment effect on its own. Then the energy level of the second source is set to a level that when combined with the first source, the combination is sufficient to produce a desired treatment effect. As a particular non-limiting example, in such an application the first source of energy may be RF radiation and the second source infrared radiation.
The principles and execution of the needle or probe, apparatus, and method described thereby may be best understood by reference to the drawings, wherein like reference numerals denote like elements through the several views and the accompanying description of non-limiting, exemplary embodiments.
Reference is made to
First end 108 of needle 100 may be shaped for piercing the skin of a subject and may be terminated by a plane perpendicular to the optical axis 118 or at an angle to the optical axis 118 of needle 100. Alternatively, end 108 may have a radius or an obtuse angle. Other shapes of needle end 108 that improve either subject skin penetration properties, facilitate needle or probe movement inside fibrotic fatty tissue, or laser power delivery quality are possible. In some cases, the skin incision is made by any well-known surgical means and the needle is introduced into the tissue. In an alternative embodiment laser radiation emitted through the first end 108 of needle 100, assists needle 100 into skin penetration process by providing continuous or pulsed laser power suitable for skin incision. Numeral 132 designates a handle by which the caregiver or person providing treatment holds and operates the needle. Handle 132 may include certain knobs for initiating or terminating treatment related processes. The length of needle 100 may vary from a few millimeters to a few hundred millimeters.
In some embodiments, shown in
In a bi-polar RF electrode configuration, an additional treatment progress status feedback method may be implemented. When RF energy is supplied to electrodes 422 it induces a current flow shown schematically by phantom lines 446 in the tissue between electrodes. It is known that tissue conductivity is temperature dependent. Accordingly, measuring the RF induced current value provides information on treated tissue status and allows the power and time of each of the laser radiation 442 or RF energy supplied to the target skin/tissue volume to be regulated.
Channel 532 connects to a facility for adipose tissue laser treatment products removal 824 (
Similar to the earlier disclosed exemplary embodiments, needle 700 includes one or more electrodes 716 deposited or built-in into the external surface of the needle. As shown in
Referring now to
As shown in
A side channel 822 extends from an inlet port 824 outside of tip 810 along the entire length of tip 810, along outer surface 826 and is fixedly attached thereto as by a suitable adhesive, through wall 828 to an outlet 830. Channel 822 may be operative to slidingly accommodate one or more light guide fibers 860 threaded through inlet port 824 and exiting and protruding from outlet 830.
In the embodiment shown in
As shown in
In this configuration, the area/volume of tissue to be treated and the propagation of the current is limited to the area between electrodes 832-1 and 832-2.
In the configuration illustrated in
This results in a flow of current, as depicted by broken-line arrows 870, across aperture 818 heating and liquefying any adipose tissue entering lumen 850 through aperture 818 as depicted by the arrow designated reference numeral 872.
During the procedure, the operator may manually select any one of the aforementioned electrode charge configurations, as necessary. Alternatively, the selection of the electrode charge configuration may be controlled by a controller, such as controller 1218 (see
Referring now to
A fluid delivery channel 932 extends from an inlet port 934 outside of tip 910 along the entire length of tip 910, along outer surface 926 and is fixedly attached thereto by a suitable adhesive, through wall 928 of closure 916 to an outlet 940. Channel 932 may be operative to connect via port 934 to a fluid supply line 962 supplying fluid from a fluid source (not shown). The fluid supplied through port 934, delivered via channel 932 and ejected through outlet 940 may be employed for cooling the electrodes, or any other desired part of the tip or tissue. Tumescent fluids may also be introduced into the treated tissue volume through lumen or inlet port 934 as well as other fluids. Adipose tissue treatment products and the fluid supplied to the tissue may be removed through aperture 918 and fluid and tissue removal lumen 950. In some embodiments, there may be one fluid conducting channel only and it may be used either for delivery of various fluids to the treated volume or for adipose tissue treatment products removal. There may be a switching arrangement switching as required the same channel between the two processes including valve switching or other similar technique
Lumen 850 (
The fluid delivered by fluid delivery channel 932 may also be employed to distant tissue from the tip of light guide fiber 960 to prevent carbonization or charring thereof. Alternatively or additionally, the fluid may be employed to lavage/irrigate the tissue being treated.
In accordance with another embodiment of the current tip for a tissue suction probe, tip 910 may include a dome-shaped shield 950 operative to protect the tip of light guide fiber 960 from carbonization or charring. Shield 950 may be integrally or removably attached by a screw-on, snap-on or similar type system to closure 916 thereby covering outlet 930. Alternatively, shield 950 may be integrally or removably attached to outlet 930. Shield 950 may be made of one or more materials selected from a group of glass, sapphire, quartz and other transparent heat resistant materials.
In some embodiments, the needle is long enough to connect directly to a source of laser radiation 1210 and a source of RF energy 1214. In such case, a separate cable (not illustrated) may include the RF conducting leads, which connect electrodes directly to the controller. Cooling fluid conducting and removal channels may be included in either of the cables. Controller 1218 may operate the source of laser radiation 810 and the source of RF energy in a pulse or continuous radiation mode.
Controller 1218 may further include a display 1230 with a touch screen, or a set of buttons or actuators providing a user interface and synchronizing operation of the source of laser radiation 1210 and the RF generator 1214 with the operation of facility for adipose tissue treatment products removal facility 1224 and a source of fluid 1220.
When RF energy of proper value is applied to the adipose tissue, it heats the tissue and may liquefy it. Laser radiation of proper power and wavelength when applied to the adipose tissue may destroy fibrotic pockets releasing liquefied fat. The liquefied adipose tissue may be removed or may be left in the body, where it gradually dissipates. Application of each of the energies alone requires a significant amount of energy, which is associated with high cost. Generally, the energy provided by laser radiation is more costly than that of RF energy.
The present apparatus enables a method for adipose tissue laser treatment combining the RF energy and laser radiation. For treatment, needle 100 or any other needle described above is introduced into a target tissue volume 1236 of adipose tissue 1240. RF generator becomes operative to supply lower cost RF energy to the target volume and heat it to a desired temperature. A relatively small addition of laser energy or radiation is required to liquefy target volume of adipose tissue 1236, destroy fibrotic pockets and release the liquefied fat. Both the RF energy and laser radiation may be delivered into the target tissue volume in a pulse or continuous mode and either simultaneously or subsequently in at least partially overlapping periods of time. RF energy delivered to the target tissue volume 1236 heats the volume and laser radiation source 1210 delivers additional tissue-destroying energy to target volume 1236. Both laser and RF energies may cause controllable dermal collagen heating and stimulation.
Concurrently with the operation of the source of RF energy 1214 and laser radiation source 1210, the facility for adipose tissue treatment products removal 1224 and, if necessary, fluid supply facility 1220 become operative. The caregiver or apparatus operator moves the needle inserted in the tissue back and forth and periodically changes its angle of movement.
It is known that a number of wavelengths may be conducted through the same light guide. In order to facilitate the process of treatment location observation of tissue, an additional second laser, visible through skin/tissue laser, such as a HeNe laser may be coupled to needle 100 or cable 1206. The HeNe laser, which is visible through skin, may assist the caregiver/operator in repositioning first end 108 of needle 100 (
In yet another embodiment, laser beams from two laser sources with different wavelength could be used to optimize simultaneous fat destruction and blood haemostatis. The laser wavelengths may, for example, be 1,06 micrometer wavelength provided by NdYAG laser and a 0.9 micrometer wavelength provided by a laser diode. Another suitable set of wavelength is 1.064 micron and 0.532 micron. Such combination of laser wavelength reduces the bleeding, makes the fat removal procedure safer, and shortens the patient recovery time.
In still a further embodiment, following tissue heating or almost simultaneously with tissue heating by RF energy, a pulsed IR laser, for example a Ho—Tm (Holmium-Thulium) or Er:Yag laser generating pulses in sub-millisecond or millisecond range, may be applied to the same target tissue volume 1236. During the laser pulse, the target tissue (cells and intercellular fluid) near the end 108 (
The apparatus disclosed above may also be used for skin tightening. The needle is inserted subcutaneously into a patient so that the first end of the fiber is introduced within the tissue underlying the dermis. RF energy and laser source emit radiation of suitable power that are conveyed by the needle and the electrodes to the dermis, where the radiation causes collagen destruction and shrinkage within the treatment area.
The disposable needle described enables continuous adipose tissue treatment process, significantly reduces the treatment time, makes the subject treatment more comfortable and simplifies the treatment process.
While the exemplary embodiment of the needle, apparatus and the method of treatment has been illustrated and described, it will be appreciated that various changes can be made therein without affecting the spirit and scope of the needle, apparatus or method of treatment. The scope of the needle, apparatus and the method of treatment therefore, are defined by reference to the following claims:
The present application is a continuation-in-part of the national phase application filed under 37 CFR 371 on Dec. 21, 2009 and assigned Ser. No. 12/665,916, which application is based on Patent Cooperation Treaty filing PCT/IL2009/000695, which claims priority to United States Provisional Application for Patent filed on Aug. 1, 2008 and assigned Ser. No. 61/085,424 and, the present application is a continuation-in-part of the United States patent application that was assigned Ser. No. 12/357,564, filed on Jan. 22, 2009, which application claims priority to the United States Provisional Application for patent that was filed on Jan. 24, 2008 and assigned Ser. No. 61/023,194
Number | Date | Country | |
---|---|---|---|
61085424 | Aug 2008 | US | |
61023194 | Jan 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12665916 | Aug 2011 | US |
Child | 13246838 | US | |
Parent | 12357564 | Jan 2009 | US |
Child | 12665916 | US |